SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060025
Filing Date
2024-05-15
Accepted
2024-05-15 07:00:37
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eldn-20240331.htm   iXBRL 10-Q 1429138
2 EX-31.1 eldn-ex31_1.htm EX-31.1 14299
3 EX-31.2 eldn-ex31_2.htm EX-31.2 14557
4 EX-32.1 eldn-ex32_1.htm EX-32.1 9090
5 EX-32.2 eldn-ex32_2.htm EX-32.2 9152
  Complete submission text file 0000950170-24-060025.txt   6325713

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20240331.xsd EX-101.SCH 966854
66 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20240331_htm.xml XML 989554
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 24947091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)